Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation
Publication Year 2014-04-22, Volume 111, Issue #16, Page 5884-9
Journal Title
Proceedings of the National Academy of Sciences of the United States of America
Publication Type
Journal Article
Thrombopoietin (TPO) acting via its receptor, the cellular homologue of the myeloproliferative leukemia virus oncogene (Mpl), is the major cytokine regulator of platelet number. To precisely define the role of specific hematopoietic cells in TPO-dependent hematopoiesis, we generated mice that express the Mpl receptor normally on stem/progenitor cells but lack expression on megakaryocytes and platelets (MplPF4cre/PF4cre). MplPF4cre/PF4cre mice displayed profound megakaryocytosis and thrombocytosis with a remarkable expansion of megakaryocyte-committed and multipotential progenitor cells, the latter displaying biological responses and a gene expression signature indicative of chronic TPO overstimulation as the underlying causative mechanism, despite a normal circulating TPO level. Thus, TPO signaling in megakaryocytes is dispensable for platelet production; its key role in control of platelet number is via generation and stimulation of the bipotential megakaryocyte precursors. Nevertheless, Mpl expression on megakaryocytes and platelets is essential to prevent megakaryocytosis and myeloproliferation by restricting the amount of TPO available to stimulate the production of megakaryocytes from the progenitor cell pool.
National Academy of Sciences
bone marrow, essential thrombocythemia
WEHI Research Division(s)
Cancer And Haematology; Molecular Medicine
NHMRC Grants
NHMRC/1016647 NHMRC/490037 NHMRC/57550
Rights Notice
Copyright © 2014 National Academy of Sciences

Creation Date: 2014-04-11 07:26:28
Last Modified: 2015-03-26 08:28:32
An error has occurred. This application may no longer respond until reloaded. Reload 🗙